Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients

References

• Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H R, Becker S, . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967–76.
   PubMed Web of Science ®Google Scholar
• Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, . Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263–70.
   PubMed Web of Science ®Google Scholar
• Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, . Bats are natural reservoirs of SARS-like coronaviruses. Science 2005;310:676–79.
   PubMed Web of Science ®Google Scholar
• Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, . The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399–404.
   PubMed Web of Science ®Google Scholar
• Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, . Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394–9.
   PubMed Web of Science ®Google Scholar
• Hsieh PK, Chang SC, Huang CC, Lee TT, Hsiao CW, Kou YH, . Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J Virol 2005;79:13848–55.
   PubMed Web of Science ®Google Scholar
• Jin H, Xiao C, Chen Z, Kang Y, Ma Y, Zhu K, . Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun 2005;328:979–86.
   PubMed Web of Science ®Google Scholar
• Peng H, Yang LT, Wang LY, Li J, Huang J, Lu ZQ, . Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 2006;351:466–75.
   PubMed Web of Science ®Google Scholar
• Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem Biophys Res Commun 2003;312:1159–64.
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450–4.
   PubMed Web of Science ®Google Scholar
• Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St CM, . Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet 2004;363:2122–7.
   PubMed Web of Science ®Google Scholar
• Huang J, Ma R, Wu CY. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006;24:4905–13.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Post P, Chubet R, Holtz K, McPherson C, Petric M, . A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine 2006;24:3624–31.
   PubMed Web of Science ®Google Scholar
• Tan YJ, Goh PY, Fielding BC, Shen S, Chou CF, Fu JL, . Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 2004;11:362–71.
   PubMedGoogle Scholar
• Woo PC, Lau SK, Wong BH, Tsoi HW, Fung AM, Kao RY, . Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2005;43:3054–8.
   Google Scholar
• Zhao J, Wang W, Wang GF, Li Y, Zhuang H, Xu X, . Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. J Clin Virol 2005;33:12–8.
   Google Scholar
• Wu LP, Wang NC, Chang YH, Tian XY, Na DY, Zhang LY, . Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis 2007;13:1562–4.
   PubMed Web of Science ®Google Scholar
• Fan YY, Huang ZT, Li L, Wu MH, Yu T, Koup RA, . Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol 2009;154:1093–9.
   PubMed Web of Science ®Google Scholar
• Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, . Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. PLoS One 2006;1:e24.
   PubMed Web of Science ®Google Scholar
• Wong SK, Li W, Moore MJ, Choe H, Farzan M. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. J Biol Chem 2004;279:3197–201.
   PubMed Web of Science ®Google Scholar
• Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, . A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561–4.
   PubMed Web of Science ®Google Scholar
• He Y, Li J, Heck S, Lustigman S, Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. J Virol 2006;80:5757–67.
   PubMed Web of Science ®Google Scholar
• Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, . Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci USA 2004;101:9804–9.
   PubMed Web of Science ®Google Scholar
• Yang ZY, Kong WP, Huang Y, Roberts A, Murphy BR, Subbarao K, . A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004;428:561–4.
   PubMed Web of Science ®Google Scholar
• Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, . Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003;362:1895–6.
   PubMed Web of Science ®Google Scholar
• Hiscox JA, Cavanagh D, Britton P. Quantification of individual subgenomic mRNA species during replication of the coronavirus transmissible gastroenteritis virus. Virus Res 1995;36:119–30.
   Google Scholar
• Burton DR. Antibodies, viruses and vaccines. Nat Rev Immunol 2002;2:706–13.
   PubMed Web of Science ®Google Scholar
• Cao WC, Liu W, Zhang PH, Zhang F, Richardus JH. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med 2007;357:1162–3.
   PubMed Web of Science ®Google Scholar
• Liu W, Fontanet A, Zhang PH, Zhan L, Xin ZT, Baril L, . Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome. J Infect Dis 2006;193:792–5.
   PubMed Web of Science ®Google Scholar
• Mo H, Zeng G, Ren X, Li H, Ke C, Tan Y, . Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology 2006;11:49–53.
   PubMed Web of Science ®Google Scholar
• Fukushi S, Mizutani T, Saijo M, Kurane I, Taguchi F, Tashiro M, . Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J Med Virol 2006;78:1509–12.
   PubMed Web of Science ®Google Scholar
• Han DP, Kim HG, Kim YB, Poon LL, Cho MW. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 2004;326:140–9.
   PubMed Web of Science ®Google Scholar
• Wang S, Sakhatskyy P, Chou TH, Lu S. Assays for the assessment of neutralizing antibody activities against severe acute respiratory syndrome (SARS) associated coronavirus (SCV). J Immunol Methods 2005;301:21–30.
   PubMed Web of Science ®Google Scholar
• Nie Y, Wang G, Shi X, Zhang H, Qiu Y, He Z, . Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 2004;190:1119–26.
   PubMed Web of Science ®Google Scholar
• Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, . Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 2005;11:411–6.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang F, Yu W, He T, Yu J, Yi CE, . Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol 2006; 78:1–8.
   PubMed Web of Science ®Google Scholar
• He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, . Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology 2005;334: 74–82.
   PubMed Web of Science ®Google Scholar
• He Y, Lu H, Siddiqui P, Zhou Y, Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 2005;174:4908–15.
   PubMed Web of Science ®Google Scholar